0000000000180077
AUTHOR
K. König
Charge Radii of ^{55,56}Ni Reveal a Surprisingly Similar Behavior at N=28 in Ca and Ni Isotopes.
Nuclear charge radii of $^{55,56}$Ni were measured by collinear laserspectroscopy. The obtained information completes the behavior of the chargeradii at the shell closure of the doubly magic nucleus $^{56}$Ni. The trend ofcharge radii across the shell closures in calcium and nickel is surprisinglysimilar despite the fact that the $^{56}$Ni core is supposed to be much softerthan the $^{48}$Ca core. The very low magnetic moment$\mu(^{55}\mathrm{Ni})=-1.108(20)\,\mu_N$ indicates the impact of M1excitations between spin-orbit partners across the $N,Z=28$ shell gaps. Ourcharge-radii results are compared to \textit{ab initio} and nuclear densityfunctional theory calculations, showing good agreeme…
Chromatographie von Metallchelaten
Die leichte Zuganglichkeit di-substituierter Dithiocarbamate erlaubt es, in einem breiteren Rahmen den Effekt unterschiedlicher Substitution auf die Trennung der Metall-dithiocarbamate (DTC) durch die Dunnschicht-Chromatographie zu untersuchen.
Compliance and arthralgias in clinical therapy (COMPACT): Assessment of the incidence of arthralgia, therapy costs, and compliance in the first year of adjuvant anastrozole.
e11040^ Background: Aromatase Inhibitors (AI) are well established as adjuvant endocrine treatment for postmenopausal women with HR+ early breast cancer (EBC). However, clinical trial data show higher frequently of arthralgia with AI than tamoxifen. As arthralgia may be greatly influencing compliance to adjuvant therapy, we designed a prospective trial to collect real world data on the effects of AI-associated arthralgia on patient compliance, patient outcomes and treatment costs of arthralgia. Methods: COMPACT is an open, prospective non-interventional study (NCT00857012) assessing the incidence of arthralgia, therapy costs, and compliance within the first year of adjuvant anastrozole (AN…
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer
Geburtshilfe und Frauenheilkunde 78(11), 1056-1088 (2018). doi:10.1055/a-0646-4630
On the performance of wavelength meters : Part 1 : consequences for medium-to-high-resolution laser spectroscopy
Present-day laser-spectroscopy experiments increasingly rely on modern commercial devices to monitor, stabilize, and scan the wavelength of their probe laser. Recently, new techniques are capable of achieving unprecedented levels of precision on atomic and nuclear observables, pushing these devices to their performance limits. Considering the fact that these observables themselves are deduced from the frequency difference between specific atomic resonances, in the order of MHz–GHz, the uncertainty on the output of the device measuring the wavelength is often directly related to the final systematic uncertainty on the experimental results. Owing to its importance, the performance of several …
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer
62. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, DGGG'18, Berlin, Germany, 31 Oct 2018 - 3 Nov 2018; Geburtshilfe und Frauenheilkunde 78(10), 927-948 (2018). doi:10.1055/a-0646-4522 special issue: "62. Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, DGGG'18, Berlin, 31.10 – 03.11.2018 : Frauenheilkunde im Fokus: wissenschaftlich fundiert und der Qualität verpflichtet"